Ensitrelvir is an oral antiviral that suppresses the replication of SARS-CoV-2 by selectively inhibiting the viral 3CL protease.
The investment is part of Croda’s continuing commitment to develop high performance pharmaceutical ingredients and technologies for life sciences.
Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth
The increased drug load enabled by the nanoformed particles also allows smaller implants with sustained release properties to be developed.
Convergent action on AMR identified as an important area of intervention
Investment enables development of revolutionary multi-omic platform using super-resolution imaging technology for earlier disease detection and accelerated discovery of therapeutics
Total investments could reach €70 million, of which approximately 15% in R&D and 85% in capex, that would be deployed from 2026
Agreement provides customers in the majority of Europe* access to supply through Univar Solutions distribution network
The new recycling facility, Recover Louth, is the second addition to Coveris’ closed loop recycling business segment
Subscribe To Our Newsletter & Stay Updated
